We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

AI Detects COVID-19 in Lung Ultrasound Images

By HospiMedica International staff writers
Posted on 21 Mar 2024
Print article
Image: The automated detection tool could help ER doctors diagnose COVID-19 patients quickly and accurately (Photo courtesy of Adobe Stock)
Image: The automated detection tool could help ER doctors diagnose COVID-19 patients quickly and accurately (Photo courtesy of Adobe Stock)

During the onset of the pandemic, utilizing artificial intelligence (AI) to identify signs of COVID-19 in lung ultrasound images proved challenging due to limited patient data and a nascent understanding of the disease's manifestations. Though computational tools were applied to help detect COVID-19 from these images, the risk of misdiagnosis was high without adequately training and validating the AI to recognize features specific to COVID-19 in the lungs. Now, new research has led to the development of an AI tool that is capable of identifying COVID-19 in lung ultrasound images, similar to how facial recognition technology identifies faces in a crowd.

The AI tool developed by researchers at Johns Hopkins (Baltimore, MD, USA) is a deep neural network, a type of AI designed to mimic the interconnected neurons that enable the brain to recognize patterns, understand speech, and complete complex tasks. The AI tool employs algorithms to scan through lung ultrasound images for spotting features known as B-lines. These features are visible as bright, vertical abnormalities and are indicators of inflammation in patients with pulmonary complications. By learning from a combination of real and simulated data, it detects abnormalities in ultrasound scans that indicate a person has contracted COVID-19.

The findings of the research significantly enhance AI's role in medical diagnostics, helping healthcare professionals to promptly diagnose COVID-19 and other lung diseases. In addition to providing clinicians with the tool to rapidly assess the overwhelming number of patients in emergency rooms during a pandemic, the tool also paves the way for the development of wearables to monitor illnesses such as congestive heart failure, which can result in fluid overload in patients’ lungs, similar to COVID-19.

“We developed this automated detection tool to help doctors in emergency settings with high caseloads of patients who need to be diagnosed quickly and accurately, such as in the earlier stages of the pandemic,” said Muyinatu Bell, the John C. Malone Associate Professor of Electrical and Computer Engineering, Biomedical Engineering, and Computer Science at Johns Hopkins University. “Potentially, we want to have wireless devices that patients can use at home to monitor progression of COVID-19, too.”

“Early in the pandemic, we didn’t have enough ultrasound images of COVID-19 patients to develop and test our algorithms, and as a result our deep neural networks never reached peak performance,” said Lingyi Zhao, who developed the software while a postdoctoral fellow in Bell’s lab. “Now, we are proving that with computer-generated datasets we still can achieve a high degree of accuracy in evaluating and detecting these COVID-19 features.”

Related Links:
Johns Hopkins

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Solid State Kv/Dose Multi-Sensor
Silver Member
Wireless Mobile ECG Recorder
Self-Driving Mobile C-arm

Print article


Critical Care

view channel
Image: This study is significant as it addresses a treatment approach that has not been extensively studied before (Photo courtesy of 123RF)

Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease

There has been a lack of extensive research on the use of drug-coated balloon (DCB)-only strategy for the treatment of de novo left main coronary artery disease, especially in high bleeding risk (HBR) patients.... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.